Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-10-22

FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ramipril submitted by Hikma Pharmaceuticals USA Inc. The action confirms continued approval of the ramipril gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)